Neil Fanger
Gründer bei Rise Therapeutics LLC
Ursprung des Netzwerks ersten Grades von Neil Fanger
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Rise Therapeutics LLC
 Rise Therapeutics LLC BiotechnologyHealth Technology Rise Therapeutics LLC develops immunological-based biologics using proprietary oral delivery platform. It offers drugs for the treatment of inflammation, autoimmunity, and cancer. The company was founded by Gary Fanger and Neil Fanger on September 4, 2014 and is headquartered in Rockville, MD.
1
| Holding Company | Biotechnology | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Neil Fanger
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Seattle University | College/University | Masters Business Admin | |
| Dartmouth College | College/University | Doctorate Degree | |
| Denison University | College/University | Undergraduate Degree | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Corporate Officer/Principal | |
EpicentRx, Inc.
 EpicentRx, Inc. Pharmaceuticals: MajorHealth Technology EpicentRx, Inc. develops compounds sourced and adapted from the aerospace industry for treating cancer. Its technology includes chemical platform, RRx-001 overview, rons potential, epigenetics, collaboration and immunotherapy. The company was founded by Susan J. Knox and Mark Bednarski and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
OncoImmune, Inc.
 OncoImmune, Inc. Pharmaceuticals: MajorHealth Technology OncoImmune, Inc. engages in the research and development of biopharmaceuticals for the treatment of cancer and autoimmune diseases. It offers CD24Fc, a recombinant fusion protein that targets a novel immune pathway checkpoint; Sialidase Inhibitors, ONC-392, and Echinomycin. The company was founded by Kun-Liang Guan, Ming You, Yang Liu, and Pan Zheng in 2000 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 8 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 2 |
| Masters Business Admin | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Gary Fanger | 8 |
- Börse
- Insiders
- Neil Fanger
- Unternehmensverbindungen
